Neurizon Therapeutics LimitedASX: NUZ

Epichem Gains 51% Interest in JV for New Diabetes Treatment

Feb 10, 2016 at 8:19 PM EST · Issued by Neurizon Therapeutics Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

6ix hasn’t read this filing yet.

Follow Neurizon Therapeutics into a list and get an email when it puts out news.